TCL Archive NCI Advisors Approve New Grant Programs In Systems Genetics, Tumor Stem Cells. November 23, 2007
TCL Archive Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs June 16, 1999
TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980